IFNA1 and neoplasm: In the last years, pDCs have been identified among the restricted cell subsets expressing the IFN-λ functional receptor (IFNλR) other than producers of type III interferons (IFN-λ or IL-28/IL-29), which play potent anti-viral activities and trigger IFN-α production during tumor progression (23).